D
Portage Biotech Inc. PRTG
$5.42 -$0.54-9.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 0.00% -37.90% 17.87% 93.35% 36.79%
Total Depreciation and Amortization 0.00% 42.86% -12.50% -38.46% -13.33%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 0.00% 566.48% 90.95% -104.56% -38.94%
Change in Net Operating Assets 0.00% 387.07% -111.98% 409.27% -47.64%
Cash from Operations 0.00% 28.97% 7.47% 45.98% 9.04%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% -40.00% -11.11% 25.00% -9.09%
Issuance of Common Stock 0.00% -- -100.00% -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 0.00% 10,710.00% -25.00% -100.00% -100.08%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 0.00% 97.01% 7.32% -441.21% -116.51%